Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma.

Anticancer research - 1 Oct 2016

Hayashi Takuma, Kawano Miki, Ichimura Tomoyuki, Ida Koichi, Ando Hirofumi, Zharhary Dorit, Kanai Yae, Aburatani Hiroyuki, Tonegawa Susumu, Shiozawa Tanri, Yaegashi Nobuo, Konishi Ikuo

Abstract excerpt

Patients with uterine leiomyosarcoma (LMS) typically present with vaginal bleeding, pain, and a pelvic mass, with atypical presentations of hypercalcemia and eosinophilia also being reported. Radiographic evaluation with combined positron-emission tomography/computed tomography may assist in diagnosis and surveillance in women with uterine LMS; these are commonly used with stage and tumour grade as prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cysteine Endopeptidases
Share to JAK1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to STAT1 gene

Share to Interferon-gamma

Share to Leiomyosarcoma

Share to Mutation

Share to Uterine Neoplasms

Source

Identifiers

PMID: 27798858
DOI: 10.21873/anticanres.11068

Genes

PSMB9
JAK1
STAT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma.PMID 27798858Read ↗

Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Semantic proximity Read ↗

Efficacy of Antitumor Drugs Against Uterine Leiomyosarcoma Obtained Through the Analysis of LMP2-Deficient Mice and the Result from a Cancer Gene Panel at Cancer Genomic MedicineSemantic proximity Read ↗

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaSemantic proximity Read ↗

The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.Semantic proximity Read ↗

Recent developments in uterine mesenchymal neoplasms.Semantic proximity Read ↗

The Future of Targeted Therapy for LeiomyosarcomaSemantic proximity Read ↗

Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.Semantic proximity Read ↗

Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.Semantic proximity Read ↗

The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine LeiomyosarcomaSemantic proximity Read ↗

Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient BenefitSemantic proximity Read ↗

Molecular and Cellular Insights into the Development of Uterine Fibroids.Semantic proximity Read ↗

Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single InstitutionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.